DTIL - CIK 0001357874
PRECISION BIOSCIENCES INC (DTIL) reported net income of -$45.72M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$45.72M | -738.0% |
| FY 2024 | $7.17M | +111.7% |
| FY 2023 | -$61.32M | +45.1% |
| FY 2022 | -$111.64M | -264.8% |
| FY 2021 | -$30.60M | +71.9% |
| FY 2020 | -$109.01M | -17.4% |
| FY 2019 | -$92.88M | -101.7% |
| FY 2018 | -$46.04M | - |
PRECISION BIOSCIENCES INC (DTIL) reported net income of -$45.72M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, PRECISION BIOSCIENCES INC's net income grew from -$46.04M to -$45.72M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.